| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 1.42 | 2.06 | 3.02 | 0.89 |
| Receivables | 0.13 | 0.51 | 0.36 | 0.25 |
| Inventory | 4.16 | 6.45 | 5.99 | 4.02 |
| Other | 0.06 | 0.22 | 0.09 | 1.53 |
| 5.94 | 9.71 | 9.98 | 6.95 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 4.92 | 6.13 | 8.05 | 9.05 |
| ST’ Debt | 0.70 | 2.13 | 1.12 | 1.11 |
| Other | 0.21 | 0.08 | 0.04 | 0.05 |
| 8.58 | 11.94 | 12.71 | 13.58 |
| 10y | 5y | 3y | |
| Sales | — | — | — |
| Cash Flow | — | — | — |
| Earnings | — | — | — |
| Book Value | — | — | — |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 18.25 | 16.61 | — | — |
—
|
| ’25 | 20.26 | 20.20 | 19.04 | 18.71 |
78.21
|
| ’24 | 15.89 | 15.59 | 18.23 | 19.65 |
69.37
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (0.20) | (1.00) | — | — |
—
|
| ’25 | 1.09 | 1.07 | (0.31) | (0.85) |
1.00
|
| ’24 | (2.55) | (0.45) | (0.96) | 0.90 |
(3.06)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (0.27) | (1.14) | — | — |
—
|
| ’25 | 0.97 | 0.99 | (0.35) | (0.92) |
0.69
|
| ’24 | (2.62) | (0.50) | (0.24) | 0.79 |
(2.57)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (5.94) | (3.85) | — | — |
—
|
| ’25 | (2.45) | (1.05) | (3.15) | (1.75) |
(8.39)
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | 26.74 | 7.74 | — | — | — |
Low Price
|
| — | — | — | — | — | — | — | — | 297.50 | 82.25 | — | — | — |
High Price
|
| — | — | — | — | — | — | — | 500 | 450 | 430 | — | — | — |
Employees
|
| — | — | — | — | — | — | — | 0.11 | 0.15 | 0.18 | — | — | — |
Revenue/Emp
|
| — | — | — | — | — | — | — | 55.69 | 69.37 | 78.21 | ‡‡‡‡‡ | — | — |
Revenue
|
| — | — | — | — | — | — | — | 36.54% | 39.02% | 39.20% | — | — | — |
Gross Margin
|
| — | — | — | — | — | — | — | (9.93) | (4.51) | (3.94) | — | — | — |
EBT
|
| — | — | — | — | — | — | — | (17.84%) | (6.50%) | (5.03%) | ‡‡‡ | — | — |
EBT Margin
|
| — | — | — | — | — | — | — | (9.93) | (4.51) | (3.94) | ‡‡‡‡‡ | — | — |
Net Income
|
| — | — | — | — | — | — | — | 10.11 | 4.85 | 5.45 | — | — | — |
Depreciation
|
| — | — | — | — | — | — | — | 211.03 | 258.17 | 165.03 | ‡‡‡‡‡ | — | — |
Revenue/Sh
|
| — | — | — | — | — | — | — | — | (16.78) | (8.39) | ‡‡‡‡‡ | — | — |
Earnings/Sh
|
| — | — | — | — | — | — | — | (9.57) | (11.41) | 2.10 | — | — | — |
Cash Flow/Sh
|
| — | — | — | — | — | — | — | (0.68) | 1.85 | (0.65) | ‡‡‡ | — | — |
Capex/Sh
|
| — | — | — | — | — | — | — | (10.25) | (9.56) | 1.45 | — | — | — |
Free CF/Sh
|
| — | — | — | — | — | — | — | 34.06 | 8.86 | 15.41 | — | — | — |
Book Value/Sh
|
| — | — | — | — | — | — | — | 0.26 | 0.27 | 0.47 | ‡‡‡‡‡ | — | — |
Shares
|
| — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | ‡‡‡‡‡ | — | — |
PE Ratio
|
| — | — | — | — | — | — | — | 0.00 | 0.16 | 0.05 | ‡‡‡ | — | — |
PS Ratio
|
| — | — | — | — | — | — | — | 0.00 | 4.66 | 0.57 | ‡‡‡ | — | — |
PB Ratio
|
| — | — | — | — | — | — | — | 0.00 | 0.29 | 0.11 | ‡‡‡‡ | — | — |
EV/Sales
|
| — | — | — | — | — | — | — | (8.31) | (7.94) | 12.47 | — | — | — |
EV/FCF
|
| — | — | — | — | — | — | — | (2.53) | (3.06) | 1.00 | ‡‡‡ | — | — |
Op' Cash Flow
|
| — | — | — | — | — | — | — | (0.18) | 0.50 | (0.31) | ‡‡‡‡‡ | — | — |
Capex
|
| — | — | — | — | — | — | — | (2.70) | (2.57) | 0.69 | — | — | — |
FCF
|
| — | — | — | — | — | — | — | (2.63) | (2.23) | (2.73) | — | — | — |
Working Cap'
|
| — | — | — | — | — | — | — | 3.11 | 11.34 | 7.42 | — | — | — |
Total Debt
|
| — | — | — | — | — | — | — | 1.68 | 9.28 | 4.40 | — | — | — |
Net Debt
|
| — | — | — | — | — | — | — | 8.99 | 2.38 | 7.31 | — | — | — |
Sh' Equity
|
| — | — | — | — | — | — | — | 0.00% | (14.41%) | (11.64%) | — | — | — |
ROA
|
| — | — | — | — | — | — | — | (61.63%) | (9.53%) | (13.26%) | — | — | — |
ROIC
|
| — | — | — | — | — | — | — | 0.00% | (79.28%) | (81.28%) | — | — | — |
ROE
|
Healthy Choice Wellness Corp. (HCWC) shows promising revenue momentum in the recovering wellness sector, with sales surging 25% to $69.4 million in 2024 and projected to grow at a 15% CAGR through 2026, fueled by higher efficiency per employee and expanding gross margins from 36.5% to 39%. Yet, persistent losses—narrowing but still negative at -$4.5 million EBT in 2024—coupled with nearly 97% share dilution, erode per-share value and cast shadows on this growth story, making it a classic high-risk small-cap turnaround.
The balance sheet raises red flags for conservative investors: net debt ballooned 451% to $9.3 million, shareholders’ equity plunged 74% to $2.4 million, and free cash flow remains deeply negative amid ongoing burn. ROE at -79% and negative working capital underscore liquidity strains in a high-interest environment, though forecasts hint at breakeven EBT and positive FCF by 2026 if execution holds.
Trading at rock-bottom valuations (0.16x P/S), HCWC’s volatile stock—down sharply from 2024 highs—entices with unanimous analyst targets implying 640% upside, but dilution, debt, and execution risks demand caution. This lottery-like play suits only tiny portfolio allocations; the full analysis unpacks whether fundamentals can overcome the downside pitfalls.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.